ImmunoGen Inc
XMUN:IMU
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
I
|
ImmunoGen Inc
XMUN:IMU
|
US |
|
U
|
US Bancorp
BMV:USB
|
US |
|
B
|
Bank of Montreal
F:BZZ
|
CA |
|
C
|
CME Group Inc
F:MX4A
|
US |
|
H
|
Hartford Financial Services Group Inc
XMUN:HFF
|
US |
|
M
|
Motorola Solutions Inc
XMUN:MTLA
|
US |
|
C
|
CME Group Inc
DUS:MX4A
|
US |
|
E
|
Expeditors International of Washington Inc
DUS:EW1
|
US |
|
P
|
Pfizer Inc
XMUN:PFE
|
US |
|
CK Hutchison Holdings Ltd
F:2CKA
|
HK |
|
MERLIN Properties SOCIMI SA
F:MEQA
|
ES |
|
Scor SE
F:SDRB
|
FR |
|
Empire Metals Ltd
LSE:EEE
|
UK |
|
D
|
Dover Corp
XBER:DOV
|
US |
|
N
|
Nikon Corp
DUS:NKN
|
JP |
|
E
|
Equinor ASA
DUS:DNQ
|
NO |
|
F
|
First Tractor Co Ltd
XMUN:FTP
|
CN |
|
C
|
Coloplast A/S
F:CBH
|
DK |
|
Verastem Inc
F:2VSA
|
US |
Bankruptcy Probability
ImmunoGen Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
ImmunoGen Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
I
|
ImmunoGen Inc
XETRA:IMU
|
1.7B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| JP |
|
Takara Bio Inc
TSE:4974
|
120.4T JPY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
406.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
186.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
155.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
118.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
64.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
49.3B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
ImmunoGen Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, ImmunoGen Inc has total debt of 88.6m USD. This includes both short-term (0 USD) and long-term (88.6m USD) debt.
You can find a full breakdown on its Balance Sheet.
